Screener
Parabilis Medicines PBLS Cash Flow Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q2 '25 | ||
|---|---|---|---|---|---|
| -$44.49M— | -$52.46M-50.7% | -$45.32M-18.2% | -$34.81M— | ||
| $602K— | —— | —— | —— | ||
| $2.74M— | —— | —— | —— | ||
| -$41.08M— | —— | —— | —— | ||
| $611K— | —— | —— | —— | ||
| -$518.28M— | —— | —— | —— | ||
| -$41.69M— | —— | —— | —— |
FAQ
- Where does Parabilis Medicines's cash flow data come from?
- Every line is extracted from Parabilis Medicines's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.